Companies: 10,795·Total market cap: $144.5T
Simulations Plus, Inc.

Simulations Plus, Inc.

SLPNASDAQHealthcare● Active
$15.91
+$0.03(+0.19%)
Market Cap$321469219
P/E Ratio—
52W High$28.44
52W Low$11.09
Overview
Stock ranking:Medical - Healthcare Information Services·Healthcare·View All Market Cap Rankings →

Simulations Plus, Inc. (SLP) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · SLP · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-3.12slp eps ttm · slp earnings per shareEarnings history
PE Ratio (TTM)—slp pe ratio ttm · slp price to earningsPE Ratio deep dive
Revenue (TTM)$80.5Mslp revenue ttm · slp annual revenueFull revenue history
Dividend Yield0.60%does slp pay dividends · slp dividend yieldDividend history
Shares Outstanding20.1Mslp shares outstanding · slp floatShares outstanding history
Next EarningsJul 13, 2026Est.slp earnings date · slp next earningsEarnings history

Explore Simulations Plus, Inc. Data

slp stock data · financials
Market Cap$321.5Mslp market cap · slp valuation
Analyst Forecast$56 · Buy
Dividends0.60%does simulations plus, inc. pay dividends · slp dividend yield
Revenue$79.2M+13.09%simulations plus, inc. annual revenue · slp revenue
EarningsEPS $-3.22-744.00%slp earnings · slp eps
PE Ratio—slp pe ratio · slp price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$79.2M▲ +13.09% YoY
202320242025
simulations plus, inc. revenue · slp revenue 2025
FY 2025Net Income-$64.7M▼ 750.17% YoY
202320242025
simulations plus, inc. net income · slp profit 2025
FY 2025EPS$-3.22▼ 744.00% YoY
202320242025
slp eps · simulations plus, inc. earnings per share 2025
TTM:Revenue: $80.5MNet Income: -$62.8MEPS: $-3.12View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy8 analystsis slp a buy · slp analyst rating
Strong Buy
0
Buy
4
Hold
4
Sell
0
Strong Sell
0
12-Month Price Target
$47.00Low
$15.91Current
$56.00Avg Target251.98% upside
$65.00High
slp price target · slp 12 month forecast

Total: 8 · Buy rate: 50.0%

The SLP analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $56.00, representing +251.98% upside from the current price of $15.91.

Stock Performance

Full History
1D+0.19%
1W-3.58%
1M-4.62%
3M+30.20%
YTD-12.73%
1Y-42.00%
5Y-70.91%

About Simulations Plus, Inc.

CEOShawn O'Connor
IPO DateJun 18, 1997
Employees243
CountryUS
Websitesimulations-plus.com

Simulations Plus, Inc. (SLP) is a worldwide developer of sophisticated software and services aimed at enhancing drug discovery and development processes. The company employs artificial intelligence an…

Medical - Healthcare Information ServicesHealthcareNASDAQUS

what is simulations plus, inc. · slp stock overview · simulations plus, inc. company profile · who is simulations plus, inc. ceo · slp NASDAQ · simulations plus, inc. headquarters · simulations plus, inc. business segments

About Stock Overview & Key Data

Simulations Plus, Inc. (SLP) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Jun 18, 1997. As of the latest trading session, SLP stock price is $15.91, with a market capitalization of $321.5M. The stock has returned -42.00% over the past 12 months and -12.73% year-to-date.

According to 8 Wall Street analysts, the consensus rating for Simulations Plus, Inc. stock is Buy, with an average 12-month price target of $56.00. In fiscal year 2025, Simulations Plus, Inc. reported revenue of $79.2M and net income of -$64.7M. For detailed data — including Simulations Plus, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Simulations Plus, Inc. (SLP) stock price is $15.91. The stock is traded on NASDAQ under the ticker symbol SLP. The 52-week range is $11.09 – $28.44.

SLP stock priceSLP quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice